AIRLINK 167.01 Decreased By ▼ -1.50 (-0.89%)
BOP 9.75 Decreased By ▼ -0.04 (-0.41%)
CNERGY 7.78 Decreased By ▼ -0.21 (-2.63%)
CPHL 88.70 Increased By ▲ 0.73 (0.83%)
FCCL 44.99 Increased By ▲ 1.06 (2.41%)
FFL 15.25 Decreased By ▼ -0.27 (-1.74%)
FLYNG 28.10 Increased By ▲ 0.16 (0.57%)
HUBC 140.20 Increased By ▲ 2.23 (1.62%)
HUMNL 12.56 Increased By ▲ 0.19 (1.54%)
KEL 4.22 Decreased By ▼ -0.02 (-0.47%)
KOSM 5.50 Decreased By ▼ -0.06 (-1.08%)
MLCF 67.40 Increased By ▲ 2.61 (4.03%)
OGDC 213.50 Increased By ▲ 1.81 (0.86%)
PACE 5.54 Decreased By ▼ -0.19 (-3.32%)
PAEL 44.45 Decreased By ▼ -0.57 (-1.27%)
PIAHCLA 16.85 Decreased By ▼ -0.24 (-1.4%)
PIBTL 9.36 Increased By ▲ 0.13 (1.41%)
POWER 14.31 Decreased By ▼ -0.14 (-0.97%)
PPL 163.99 Decreased By ▼ -2.41 (-1.45%)
PRL 29.29 Decreased By ▼ -1.36 (-4.44%)
PTC 21.51 Increased By ▲ 0.31 (1.46%)
SEARL 88.51 Decreased By ▼ -1.96 (-2.17%)
SSGC 40.50 Decreased By ▼ -0.55 (-1.34%)
SYM 14.79 Increased By ▲ 0.31 (2.14%)
TELE 7.17 Decreased By ▼ -0.22 (-2.98%)
TPLP 9.19 Decreased By ▼ -0.18 (-1.92%)
TRG 64.35 Decreased By ▼ -0.65 (-1%)
WAVESAPP 9.42 Decreased By ▼ -0.09 (-0.95%)
WTL 1.29 Decreased By ▼ -0.02 (-1.53%)
YOUW 3.65 Decreased By ▼ -0.07 (-1.88%)
AIRLINK 167.01 Decreased By ▼ -1.50 (-0.89%)
BOP 9.75 Decreased By ▼ -0.04 (-0.41%)
CNERGY 7.78 Decreased By ▼ -0.21 (-2.63%)
CPHL 88.70 Increased By ▲ 0.73 (0.83%)
FCCL 44.99 Increased By ▲ 1.06 (2.41%)
FFL 15.25 Decreased By ▼ -0.27 (-1.74%)
FLYNG 28.10 Increased By ▲ 0.16 (0.57%)
HUBC 140.20 Increased By ▲ 2.23 (1.62%)
HUMNL 12.56 Increased By ▲ 0.19 (1.54%)
KEL 4.22 Decreased By ▼ -0.02 (-0.47%)
KOSM 5.50 Decreased By ▼ -0.06 (-1.08%)
MLCF 67.40 Increased By ▲ 2.61 (4.03%)
OGDC 213.50 Increased By ▲ 1.81 (0.86%)
PACE 5.54 Decreased By ▼ -0.19 (-3.32%)
PAEL 44.45 Decreased By ▼ -0.57 (-1.27%)
PIAHCLA 16.85 Decreased By ▼ -0.24 (-1.4%)
PIBTL 9.36 Increased By ▲ 0.13 (1.41%)
POWER 14.31 Decreased By ▼ -0.14 (-0.97%)
PPL 163.99 Decreased By ▼ -2.41 (-1.45%)
PRL 29.29 Decreased By ▼ -1.36 (-4.44%)
PTC 21.51 Increased By ▲ 0.31 (1.46%)
SEARL 88.51 Decreased By ▼ -1.96 (-2.17%)
SSGC 40.50 Decreased By ▼ -0.55 (-1.34%)
SYM 14.79 Increased By ▲ 0.31 (2.14%)
TELE 7.17 Decreased By ▼ -0.22 (-2.98%)
TPLP 9.19 Decreased By ▼ -0.18 (-1.92%)
TRG 64.35 Decreased By ▼ -0.65 (-1%)
WAVESAPP 9.42 Decreased By ▼ -0.09 (-0.95%)
WTL 1.29 Decreased By ▼ -0.02 (-1.53%)
YOUW 3.65 Decreased By ▼ -0.07 (-1.88%)
BR100 12,327 Increased By 71.3 (0.58%)
BR30 36,803 Increased By 80.1 (0.22%)
KSE100 115,469 Increased By 449.5 (0.39%)
KSE30 35,563 Increased By 234.3 (0.66%)

KARACHI: As Pakistan’s pharmaceutical industry looks to evolve amidst local and global challenges, the 7th Pakistan Pharma Summit and PESA Awards 2024 are set to take place on September 25 at the Serena Hotel in Islamabad.

This year’s theme, ‘Digital Pharma Transformation: Enhancing Efficiency in Uncertain Times’, aims to explore not only technological advancements but also the critical need for collaboration, regulatory improvements, and innovative practices that will drive the industry forward.

Haroon Qassim, Managing Director of Pharmevo and Chairman of the Summit Organizing Committee, emphasised that the summit will seek to create a platform for dialogue among various stakeholders in the pharmaceutical sector. “The Pakistan Pharma Summit is more than about protecting the interests of our sector; it’s about fostering an environment of development, progress, and continuous learning,” he stated.

Regulatory environment major issue as foreign pharma cos exit Pakistan

The summit is expected to draw a diverse audience including government officials, pharmaceutical manufacturers, exporters, marketers, and representatives from allied industries. The wide-ranging participation underscores the importance of collaboration in addressing the multifaceted challenges faced by the pharmaceutical sector today.

The event will feature an array of speakers, including Sardar Ayaz Sadiq, Speaker of the National Assembly of Pakistan, and Dr Mehmood Khan, CEO of Hevolution Foundation, who will deliver the inaugural keynote address. Dr Khan’s presentation will focus on leveraging global innovation and collaboration to unlock Pakistan’s life sciences potential, emphasizing the need for strategic partnerships that can enhance both domestic capabilities and international competitiveness.

The summit will also include sessions led by renowned experts who will discuss a range of topics critical to the industry. A key address by Dr Semih Kumluk, Head of AI and Digital at PwC Academy, will delve into how AI is reshaping various facets of the pharmaceutical landscape.

In addition to these insights, participants can expect sessions on regulatory affairs, quality control, and market strategies.

One of the central themes of the summit is the importance of collaboration among stakeholders. Qassim highlighted that the summit provides an invaluable opportunity for industry leaders to engage with government officials and regulators.

“By engaging with the highest levels of government and regulators, we hope to create actionable strategies that will drive growth and efficiency,” he noted.

Former PPMA Chairman Qaiser Waheed echoed this sentiment, emphasising the need for a mindset shift within the industry. “For the past decade, we’ve worked to change the mindset of pharma entrepreneurs and MDs,” he said. “We aim to educate them about best practices that can enhance drug quality and operational efficiency.”

Waheed stressed the importance of learning from international best practices and integrating them into Pakistan’s pharmaceutical landscape. “Technology is being utilised globally to enhance drug development, documentation, and validation.

“We want Pakistan’s pharma industry to embrace automation, robotics, and AI, which we refer to as Digital 4.0 adoption.”

Regulatory frameworks are another critical area of focus for the summit. As the industry navigates complex regulatory environments, the summit will feature discussions on how to streamline processes and ensure compliance without stifling innovation. Regulatory Affairs Address by Asim Rauf, CEO of the Drug Regulatory Authority of Pakistan (DRAP), will provide insights into the government’s efforts to support the pharmaceutical industry while ensuring patient safety.

In conjunction with the summit, the PESA Awards will recognise outstanding achievements within the pharmaceutical sector. The awards ceremony will be graced by Yousuf Raza Gillani, Chairman of the Senate of Pakistan, who will serve as the chief guest. This year’s awards will honor organizations and individuals who have demonstrated excellence in innovation, quality, and service.

Leading up to the summit, a series of capacity-building workshop focusing will also be organized in Karachi.

“The potential of our sector is tremendous,” Qassim concluded. “Through collective efforts and a commitment to innovation, we can explore and expand that potential to benefit all stakeholders involved.”

Copyright Business Recorder, 2024

Comments

Comments are closed.

Syeda Adeen Sep 24, 2024 09:00pm
Showed the overall scenario on pharmaceutical industry work in Pakistan but has not provided the information on basic happenings on the different pharmaceutical companies at Pakistan.
thumb_up Recommended (0)